Skip to main content
. 2020 May 7;3(2):190–200. doi: 10.1093/jamiaopen/ooaa011

Table 3.

Percentage of total monitoring time during a 1-week longitudinal panel study with complete data for continuous sensors (spirometry and medications are summarized differently), including periods of sleep

Device/sensor 25% 50% Median 75% 100% Max
AirBeam 13.7% 22.2% 36.2% 83.3%
Accelerometer (smartwatch) 19.5% 40.2% 50.4% 75.2%
Gyroscope (smartwatch) 24.5% 45.4% 55.4% 75.3%
Heart rate (smartwatch) 6.5% 16.4% 32.4% 63.0%